FDA label
What is memantine used for?
The FDA-approved uses of memantine, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Memantine hydrochloride USP is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted memantine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Memantine Hydrochloride, tablet
Indications and Usage, quoted from the label by Ajanta Pharma USA Inc. (ANDA206528). Cross-references to other label sections are left out.
Memantine hydrochloride USP is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
Source: DailyMed label, set id 292671f2-f221-4a3d-a110-a266a9527e04, version 9, effective November 27, 2025. NDC 27241-070, one of 38 listings for this product.
Questions
What is memantine used for?
The FDA label says: “Memantine hydrochloride USP is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.”
What drug class is memantine?
FDA lists memantine in the N-methyl-D-aspartate Receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.